Vital Images, a Toshiba Medical Systems Group Co., has announced it has received FDA clearance for three-dimensional viewing through its VitreaView viewer, according to a news release (pdf).
The company describes VitreaView as a "role-based universal viewer designed for both DICOM and non-DICOM data enabling imaging from all types of DICOM modalities across the enterprise."
Vital Images also announced it has released tablet viewing capabilities for VitreaView.
"Delivering high quality products is fundamentally important to Vital; seeking FDA clearance is just a part of our standard process," said Erkan Akyuz, president and CEO of Vital Images, in the release. "It is critical that our customers have confidence in the tools they depend on for delivering care. Now with 3D and tablet capabilities available via VitreaView, our customers, particularly referring physicians and clinicians, have more functionality and easier access to the tools they need. Also, with access to images through the EMR as part of the Stage 2 Meaningful Use criteria, VitreaView integrated with a certified EMR enables the ability to meet this objective, with a toolset and infrastructure that also meets the needs of clinical users and IT administrators."
Vital Images is headquartered in Minnetonka, Minn.
Related Articles on FDA Clearances:
Teleflex Receives FDA Clearance Vascular Access Catheter
Avinger Receives FDA Clearance for Optical Coherence Tomography Catheter
LDR Receives FDA Conditional Approval for Cervical Disc